Citicoline for brain injury in newborns
Part of Brain & nervous system clinical trials.
This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a newborn admitted to the hospital.
- Your baby has moderate (grade II) or severe (grade III) hypoxic-ischemic encephalopathy (brain injury from low oxygen).
- Your baby has NOT received therapeutic hypothermia (cooling therapy).
- Your baby does NOT have a major birth defect.
- You, as the parent, agree to let your baby join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called citicoline can help newborns who had a brief lack of oxygen around birth, which can affect their brain. It aims to see if the medicine improves their recovery and brain blood flow.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
This trial is testing a treatment for newborns who had low oxygen around birth, leading to brain injury. It may help babies who did not get certain medicines before birth.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
Hear when a new Hypoxic Ischemic Encephalopathy of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.